Anabolic androgenic steroids produce dose-dependent increase in left ventricular mass in power athletes, and this effect is potentiated by concomitant use of growth hormone

International Journal of Sports Medicine

Volumn 24, Issue 5, 2003, Pages 337-343

  Karila, T A M ^a,b,c   Karjalainen, J E ^d   Mantysaari M J ^d   Viitasalo, M T ^c   Seppala T A ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d CENTRAL MILITARY HOSPITAL   (Finland)

Author keywords

Left ventricular hypertrophy; Substance abuse

Indexed keywords

ANABOLIC AGENT; GROWTH HORMONE;

ADULT; AGE; ARTICLE; ATHLETE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG ABUSE; DRUG EFFECT; DRUG POTENTIATION; DRUG SELF ADMINISTRATION; ECHOCARDIOGRAPHY; GEOMETRY; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; MALE; MULTIPLE REGRESSION; NORMAL HUMAN; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; ANABOLIC AGENTS; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ECHOCARDIOGRAPHY; GROWTH HORMONE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; WEIGHT LIFTING;

EID: 0042203780     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40702     Document Type: Article

References (38)

1. Behrent H, Boffin H. Myocardial cell lesions caused by anabolic hormone. Cell Tissue Res 1977; 181: 423-426
2. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335: 1-7
3. Caidahl K, Edén S, Bengtsson BÅ. Cardiovascular and renal effects of growth hormone. Clin Endoc 1994; 40: 393-400
4. Deligiannis AP, Mandroukas K. Noninvasive cardiac evaluation of weightlifters using anabolic steroids. Scand J Med Sci Sports 1992; 3: 37-40
5. de Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricular morphology and function. Int J Sports Med 1991; 12: 408-412
6. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Hypertension 1987; 9(suppl II): 19-26
7. Dickerman RD, Schaller F, McConathy WJ. Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid use. Cardiology 1998; 90: 145-148
8. Dickerman RD, Schaller F, Zachariah NY, McConathy WJ. Left ventricular size and function in elite bodybuilders using anabolic steroids. Clin J Sport Med 1997; 7: 90-93
9. Donike M, Geyer H, Gotzmann A, Kraft M, Mandel F, Nolteernsting E, Opfermann G, Sigmund G, Schänzer W, Zimmermann J. Dope Analysis. Official Proceedings of International Athletic Foundation World Symposium on Doping in Sport - 1987 In Bellotti P, Benzi G, Ljungqist A, ed. London: Published by the International Athletic Foundation, 1988: 53-80
10. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Sacca L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996; 334: 809-814
11. Kahaly G, Olshausen KV, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J. Arrhythmia profile in acromegaly. Eur Heart J 1992; 13: 51-56
12. Karjalainen J, Mäntysaari M, Viitasalo M, Kujala U. Left ventricular mass, geometry, and filling in endurance athletes: association with exercise blood pressure. J Appl Physiol 1997; 82: 531-537
13. Karila TAM, Koistinen H, Seppälä M, Koistinen R, Seppälä TA. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroid in substance abusing power athletes. Clin Endoc 1998; 49: 459-463
14. Klein I, Ojamaa K. Cardiovascular manifestations of endocrine disease. J Clin Endocrinol Metab 1992; 75: 339-342
15. Krieg M, Smith K, Bartsch W. Demonstration of a specific androgen receptor in rat heart muscle: relationship between binding, metabolism, and tissue levels of androgens. Endocrinology 1978; 103: 1686-1694
16. Lie JT, Grossman SJ. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980; 100: 41-52
17. Lim M, Barkan AL, Buda AJ. Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Ann Int Med 1992; 117: 719-726
18. Maron BJ. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 1986; 7: 190-203
19. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 1998; 98: 256-261
20. Mathews LS, Enberg B, Norstedt G. Regulation of rat growth hormone reseptor gene expression. J Biol Chem 1989; 17: 9905-9910
21. Melchert RB, Herron TJ, Welder AA. The effect of anabolic-androgenic steroids on primary myocardial cell cultures. Med Sci Sports Exerc 1992; 24: 266-272
22. NIDA Research Report - Steroid Abuse and Addiction: NIH Publication No. 00-3721, Revised April, 2000
23. Nieminen MS, Rämo MP, Viitasalo M, Heikkila P, Karjalainen J, Mantysaari M, Heikkila J. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 1996; 17: 1576-1583
24. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hanlein D, Willenbrock R, Anker SD, Poole-Wilson PA, Ranke MB, Dietz R. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998; 351: 1233-1237
25. Palatini P, Giada F, Garavelli G, Sinisi F, Mario L, Michieletto M, Baldo-Enzi G. Cardiovascular effects of anabolic steroids in weight-trained subjects. J Clin Pharmacol 1996; 36: 1132-1140
26. Pearson AC, Schiff M, Mrosek D, Labovitz AJ, Williams GA. Left ventricular diastolic function in weight lifters. Am J Cardiol 1986; 58: 1254-1259
27. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991; 324: 295-301
28. Pelliccia A, Spataro A, Caselli G, Maron BJ. Absence of left ventricular wall thickening in athletes engaged in intense power training. Am J Cardiol 1993; 72(14): 1048-1054
29. Rockhold RW. Cardiovascular toxity of anabolic steroids. Annu Rev Pharmacol Toxicol 1993; 33: 497-520
30. Rossi E, Zuppi P, Pennestri F, Biasucci LM, Lombardo A, de Marinis L, Loperfido F. Acromegalic cardiomyopathy: left ventricular filling and hypertrophy in active and surgically treated disease. Chest 1992; 102: 204-208
31. Rämö P. Anabolic steroids alter the hemodynamic response of the canine left ventricle. Acta Physiol Scand 1987; 130: 209-217
32. Sachtleben TR, Berg KE, Elias BA, Cheatham JP, Felix GL, Hofschire PJ. The effects of anabolic steroids; on myocardial structure and cardiovascular fitness. Med Sci Sport Exec 1993; 25: 1240-1245
33. Shapiro LM. Physiological left ventricular hypertrophy. Br Heart J 1984; 52: 130-135
34. Smallridge RC, Rajfer S, Davia J, Schaaf M. Acromegaly and the heart: an echocardiographic study. Am J Med 1979; 66: 22-27
35. Stolt A, Karila T, Viitasalo M, Mäntysaari M, Kujala U, Karjalainen J. QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids. Am J Cardiol 1999; 84: 364-366
36. Thompson PD, Sadaniantz A, Cullinane EM, Bodziony KS, Catlin DH, Torek-Both G, Douglas PS. Left ventricular function is not impaired in weight lifters who use anabolic steroids. J Am Coll Cardiol 1992; 19: 278-282
37. Tomoda H. Effect of Oxymetholone on left ventricular dimensions in heart failure secondary to idiopathic dilated cardiomyopathy or to mitral or aortic regurgitation. Am J Cardiol 1999; 83: 123-125
38. Urhausen A, Hölpes R, Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol 1989; 58: 633-640